NICO

NICO

Leading innovator in the design of automated minimally invasive neuro and spinal tissue and tumor removal instruments.

News

Navigating the Value Analysis Committee

To provide medical device and technology companies with a greater perspective on successfully navigating VACs, we spoke with four River Cities’ med tech portfolio companies that have dedicated countless hours to mastering the pathway to get innovative products in front of and approved by these ever-vigilant committees.

Two Major Publications Reveal New Study Data Showing Patients with Deadliest Form of Stroke Now Have Second Chance at Life

New evidence in hemorrhagic stroke care suggests there may now be an answer for safely treating the deadliest, most costly and debilitating form of stroke through early surgical intervention.

NICO: Seton nurse recovering well after stroke thanks to new technology

Gigi Gelvosa is an OR nurse at Seton Brain & Spine in Austin, Texas. She’s not just any OR nurse — she’s the nurse of Dr. Ziu, BrainPath user. Recently, though, she became the patient of Dr. Ziu after suffering a hemorrhagic stroke…and was the recipient of a BrainPath surgery. Watch this TV 7 news story that shares her story or survival. Dr. Ziu says THIS tube is not just any tube and without it, his nurse’s hemorrhage would have been inoperable.

Neurosurgery Device Maker Completes $15 Million Capital Raise to Address Increasing Market Demand of New Technologies for Tumor and Stroke

NICO Corporation, an Indianapolis-based neurosurgery medical device manufacturer, recently completed a $15 million capital raise important to the expansion of newly developed markets created by their technologies and systems approach to subcortical brain surgery.

NICO Announces Hemorrhagic Stroke Trial Lead by Emory University and Grady Memorial

Randomized controlled trial to help determine best course of treatment for deadliest form of stroke.

Page 1 of 512345

Status

Active

Fund

River Cities Fund IV

Year Invested

2009

City and State

Indianapolis, IN

Portfolio Manager

Carter McNabb